Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for in-situ thrombus of pulmonary arteriole of pulmonary hypertension
Backgroud:In-situ thrombosis is a significant pathophysiological basis for the development of pulmonary hypertension (PH). However, thrombolytic therapy for in-situ thrombus in PH was often hampered by the apparent side effects and the low bioavailability of common thrombolytic medications. Nanoscal...
Main Authors: | Jingtao Li, Xiaofeng Zhang, Yingying Mo, Tongtong Huang, Huaqing Rao, Zhenyuan Tan, Liuliu Huang, Decai Zeng, Chunlan Jiang, Yanfen Zhong, Yongzhi Cai, Binbin Liang, Ji Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.1038829/full |
Similar Items
-
RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy
by: Zichen Xu, et al.
Published: (2023-04-01) -
In-vivo thrombolytic efficacy of RGD modified protein-polymer conjugated urokinase nanogels
by: Xia Liu, et al.
Published: (2021-12-01) -
Successful Treatment of Free-Floating Right Ventricular Thrombus with Acute Pulmonary Embolism
by: Sanjay Singhal, et al.
Published: (2015-01-01) -
Right atrial thrombus treated with catheter directed thrombolysis
by: Harsimran Panesar, et al.
Published: (2023-12-01) -
Stroke thrombolysis or not for an intraventricular thrombus
by: Josef Finsterer, et al.
Published: (2023-03-01)